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The mechanisms that regulate neural crest EMT remain incompletely
understood. Tetraspanin 18 (Tspan18) is a member of the tetraspanin
family of transmembrane proteins that have been implicated in cell
signaling, motility and adhesion. Tspan18 is abundantly and specifi-
cally expressed in chick premigratory neural crest, but is down-
regulated when neural crest cells begin to migrate, suggesting that
Tspan18 may negatively regulate neural crest migration. Interestingly,
mRNA and protein levels of the known neural crest EMT regulator
Cadherin6B (Cad6B) decrease following Tspan18 knock-down, while
neural crest migration is inconsistently enhanced. In contrast,
Tspan18 overexpression impedes neural crest migration, which
preliminary results suggest is due in part to Cad6B stabilization.
Consistent with the fact that the neural crest transcription factor
FoxD3 regulates neural crest cell–cell adhesion and promotes
migration, FoxD3 represses Tspan18 expression. Taken together, these
data suggest that Tspan18, as a readout of FoxD3, plays an important
role in restricting neural crest migration by affecting levels of Cad6B.
Experiments are in progress to identify proteins that interact with
Tspan18 to gain insight into how dynamic interactions at the neural
crest cell surface impact migration, and may provide clues to the
mechanisms of EMT during metastasis. Supported by NIH F31
GM087951 and a U of MN Grant in Aid.
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Establishing morphogen gradients is an essential part of devel-
opment and is orchestrated in part by cell surface receptors. The
endocytic receptor LRP2/megalin is expressed on polarized epithelial
cells, and binds and endocytoses BMP4 in addition to a large cohort of
other factors. Mutations in LRP2 have been shown to cause
developmental abnormalities that affect brain, eye and kidney
development and function. Likewise, BMP4 alterations are associated
with similar developmental disease phenotypes, including cyclopia,
holoprosencephaly, anophthalmia–microphthalmia, retinal dystro-
phy and brain anomalies. In the developing and adult telencephalon,
absence of LRP2 has been shown to lead to increased levels of BMP4
which suppresses cell proliferation and induces increased apoptosis.
Recently, Lrp2 −/− zebrafish have been shown to exhibit enlarged
eye globes, myopia, elevated intraocular pressure and retinal ganglion
cell pathogenesis. Here, we use in vivo BRE:dmKO2 reporter zebrafish
to assay BMP signaling in the eye in response to retinal pigment
epithelium-specific expression of eGFP-tagged Bmp4. We take
advantage of the localized expression of Lrp2 in the RPE to study
both the persistence of eGFP-Bmp4 and the activation of the Smad1/
5/8 pathway in the presence and absence of Lrp2. We show that the
ventral aspect of the developing RPE, which shows a low basal level of
BRE:dmKO2 activity during development, is ideal to quantify BMP4
activity in response to native and ectopic antagonists.
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Several chondrodysplasias exhibiting altered growth plate (GP)
development have been identified in birds and mammals arising from
mutations affecting the biochemical properties of aggrecan. One of
these, the cmdBC mouse phenotype, results from a complete loss of
exons 2 to 18 and the consequent complete absence of mature
aggrecan (AGC). In this study, the cmdBC mouse, and a novel AGC
mouse model were utilized to dissect the role of ACG in modulating
specific signaling pathways during GP development. First, the cmdBC
mouse was crossed with the Ptc-LacZ reporter mouse to analyze the
range of hedgehog (Hh) signaling. The extent of Ptc expression was
greatly affected, with reporter gene expression found centrally
located and significantly distant from the perichondrial margin of
the GP, indicating a reduced range of Hh signaling. Second, with the
goal of elucidating the role of AGC in providing a scaffold for growth
factors, the full-length chick Agc gene was cloned and transgenic
mice (tg) were generated driving the expression of AGC core protein
under the control of the cartilage-specific Col2a promoter. The chick-
AGC-specific S103L Mab revealed robust expression of the transgene
product in the ECM of the developing GP of the tg mice. Third,
attempts to rescue the cmdBC phenotype with the chick-AGC tg lines
resulted in a successful mild-to-moderate correction of the cmd
skeletal defects; i.e. longer limbs, tail, and snout compared to
homozygous cmdBC mice. These mouse models have already proved
extremely valuable in understanding the role of AGC in regulating
certain signaling pathways during GP development.
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